Voriconazole for IPA in Chinese Patients With COPD

NCT02234739 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Invasive Pulmonary Aspergillosis
COPD

Interventions

DRUG: Voriconazole

Sponsor

Red Cross Hospital, Hangzhou, China

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]